DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Materials
Updated 1m ago
0NHS logo

Nutrien Ltd.LSE:0NHS Stock Report

Market Cap US$37.4b
Updated 1m ago
Share Price
n/a
1Y37.0%
7D-1.7%
1D-1.1%
Portfolio Value
​
View

Nutrien Ltd.

LSE:0NHS Stock Report

Market Cap: US$37.4b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Nutrien (0NHS) Stock Overview

Provides crop inputs and services. More details

0NHS fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 20.7% below our estimate of its fair value

Earnings grew by 74.6% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Earnings are forecast to decline by an average of 1.9% per year for the next 3 years

Has a high level of debt


0NHS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW439,321 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
439,321 investors already sharing narratives
US$
Current Price
US$78.2628.8% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture035b2016201920222025202620282031Revenue US$27.7bEarnings US$2.4b
Advanced
View all narratives

Nutrien Ltd. Competitors

Antofagasta

Symbol: LSE:ANTO
Market cap: UK£37.4b

Fresnillo

Symbol: LSE:FRES
Market cap: UK£22.2b

Croda International

Symbol: LSE:CRDA
Market cap: UK£4.4b

Glencore

Symbol: LSE:GLEN
Market cap: UK£71.1b

Price History & Performance

Summary of share price highs, lows and changes for Nutrien
Historical stock prices
Current Share PriceCA$78.26
52 Week HighCA$87.36
52 Week LowCA$53.05
Beta1.08
1 Month Change16.77%
3 Month Change15.96%
1 Year Change37.00%
3 Year Change22.68%
5 Year Change25.12%
Change since IPO44.29%

Recent News & Updates

Recent updates

Shareholder Returns

0NHSGB ChemicalsGB Market
7D-1.7%-1.9%-1.8%
1Y37.0%11.4%15.2%

Return vs Industry: 0NHS exceeded the UK Chemicals industry which returned 11.4% over the past year.

Return vs Market: 0NHS exceeded the UK Market which returned 15.2% over the past year.

Price Volatility

Is 0NHS's price volatile compared to industry and market?
0NHS volatility
0NHS Average Weekly Movement4.0%
Chemicals Industry Average Movement6.4%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0NHS has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0NHS's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201725,500Ken Seitzwww.nutrien.com

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products.

Nutrien Ltd. Fundamentals Summary

How do Nutrien's earnings and revenue compare to its market cap?
0NHS fundamental statistics
Market capUS$37.45b
Earnings (TTM)US$2.38b
Revenue (TTM)US$27.29b
15.7x
P/E Ratio
1.4x
P/S Ratio

Is 0NHS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0NHS income statement (TTM)
RevenueUS$27.29b
Cost of RevenueUS$18.54b
Gross ProfitUS$8.75b
Other ExpensesUS$6.37b
EarningsUS$2.38b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 05, 2026

Earnings per share (EPS)4.99
Gross Margin32.06%
Net Profit Margin8.72%
Debt/Equity Ratio43.9%

How did 0NHS perform over the long term?

See historical performance and comparison

Dividends

2.8%
Current Dividend Yield
44%
Payout Ratio

Does 0NHS pay a reliable dividends?

See 0NHS dividend history and benchmarks
When do you need to buy 0NHS by to receive an upcoming dividend?
Nutrien dividend dates
Ex Dividend DateSep 29 2026
Dividend Pay DateOct 16 2026
Days until Ex dividend16 days
Days until Dividend pay date33 days

Does 0NHS pay a reliable dividends?

See 0NHS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/12 12:54
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nutrien Ltd. is covered by 51 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Benjamin TheurerBarclays

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide